<?xml version="1.0" encoding="UTF-8"?>
                                <rss
                                    xmlns:content="http://purl.org/rss/1.0/modules/content/"
                                    xmlns:wfw="http://wellformedweb.org/CommentAPI/"
                                    xmlns:dc="http://purl.org/dc/elements/1.1/"
                                    xmlns:atom="http://www.w3.org/2005/Atom"
                                    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
                                    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
                                    xmlns:media="http://search.yahoo.com/mrss/"
                                    version="2.0"
                                >
                                    <channel>
                                        <title>Kesan Advers | MalaysiaNow</title>
                                        <link>https://www.malaysianow.com/my</link>
                                        <description>News, views and insights into Malaysian current affairs.</description>
                                        <lastBuildDate>Wed, 16 Mar 2022 10:22:19 GMT</lastBuildDate>
                                        <language>ms-MY</language>
                                        <sy:updatePeriod>hourly</sy:updatePeriod>
                                        <sy:updateFrequency>1</sy:updateFrequency>
                                        <generator>MalaysiaNow RSS</generator>
                                        <image>
                                            <title>Kesan Advers | MalaysiaNow</title>
                                            <url>https://www.malaysianow.com/logo.svg</url>
                                            <link>https://www.malaysianow.com/my</link>
                                        </image>
                                        <copyright>Copyright © 2022 MNow Media Sdn Bhd. All rights reserved.</copyright>
                                        <atom:link href="https://www.malaysianow.com/my/tag/kesan-advers/feed" rel="self" type="application/rss+xml" />
                                        
                            <item>
                                <title><![CDATA[ 451 laporan kesan sampingan vaksin selesai disiasat, tiada kes kematian berkait vaksin ]]></title>
                                <link>https://www.malaysianow.com/my/news/2022/03/16/451-laporan-kesan-sampingan-vaksin-selesai-disiasat-tiada-kes-kematian-berkait-vaksin</link>
                                <guid>https://www.malaysianow.com/my/news/2022/03/16/451-laporan-kesan-sampingan-vaksin-selesai-disiasat-tiada-kes-kematian-berkait-vaksin</guid>
                                <dc:creator><![CDATA[ Bernama ]]></dc:creator>
                                <pubDate>Wed, 16 Mar 2022 10:22:19 GMT</pubDate>
                                <description><![CDATA[ Dapatan itu adalah sebahagian dari 607 laporan AEFI serius yang diterima melibatkan kematian dalam kalangan penerima vaksin Covid-19. ]]></description>
                                false
                                <category domain="https://www.malaysianow.com/my/section/news"><![CDATA[ News ]]></category>
                                <enclosure url="https://media.malaysianow.com/wp-content/uploads/2022/03/02123647/RemajaVaccine10_Mnow_251021.jpg" length="179646" type="image/jpeg" />
                                <media:content url="https://media.malaysianow.com/wp-content/uploads/2022/03/02123647/RemajaVaccine10_Mnow_251021.jpg" width="1280" height="853" medium="image" type="image/jpeg" />
                            </item>
                        
                            <item>
                                <title><![CDATA[ NPRA terima lebih 1,000 laporan kesan sampingan berkait vaksin Pfizer ]]></title>
                                <link>https://www.malaysianow.com/my/news/2022/02/09/npra-terima-lebih-1000-laporan-kesan-sampingan-berkait-vaksin-pfizer</link>
                                <guid>https://www.malaysianow.com/my/news/2022/02/09/npra-terima-lebih-1000-laporan-kesan-sampingan-berkait-vaksin-pfizer</guid>
                                <dc:creator><![CDATA[ Bernama ]]></dc:creator>
                                <pubDate>Wed, 09 Feb 2022 00:52:57 GMT</pubDate>
                                <description><![CDATA[ Sejumlah 544 laporan diterima melibatkan vaksin Sinovac manakala AstraZeneca merekodkan 138 laporan. ]]></description>
                                false
                                <category domain="https://www.malaysianow.com/my/section/news"><![CDATA[ News ]]></category>
                                <enclosure url="https://media.malaysianow.com/wp-content/uploads/2021/09/06153819/AmbulansVaksin04_Mnow_240821.jpg" length="146466" type="image/jpeg" />
                                <media:content url="https://media.malaysianow.com/wp-content/uploads/2021/09/06153819/AmbulansVaksin04_Mnow_240821.jpg" width="1280" height="853" medium="image" type="image/jpeg" />
                            </item>
                        
                                    </channel>
                                </rss>
                                